(BTI) British American Tobacco - Ratings and Ratios
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US1104481072
Cigarettes, Vapour, Heated, Oral, Snus
Dividends
| Dividend Yield | 6.36% |
| Yield on Cost 5y | 14.41% |
| Yield CAGR 5y | 2.35% |
| Payout Consistency | 87.8% |
| Payout Ratio | 2.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 19.9% |
| Value at Risk 5%th | 30.9% |
| Relative Tail Risk | -5.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.28 |
| Alpha | 61.56 |
| CAGR/Max DD | 0.91 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.438 |
| Beta | 0.074 |
| Beta Downside | 0.095 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.48% |
| Mean DD | 9.85% |
| Median DD | 9.39% |
Description: BTI British American Tobacco December 02, 2025
British American Tobacco p.l.c. (NYSE: BTI) is a global tobacco and nicotine company that markets a broad portfolio-including combustible cigarettes, vapour, heated-tobacco, and modern oral nicotine products-through well-known brands such as Vuse, glo, Velo, Camel, Dunhill and Lucky Strike. Its distribution network spans the Americas, Europe, Asia-Pacific, the Middle East, Africa and the United States, and the firm is headquartered in London, United Kingdom.
Key recent metrics: FY 2023 net revenue was $27.3 billion, with an adjusted operating margin of 31 %-the highest in the sector, driven largely by a ~15 % share of next-generation products (NGPs) in total sales, which grew ≈ 20 % YoY. The company’s free-cash-flow conversion remains above 70 %, supporting its £2 billion annual dividend. Sector-level drivers include declining smoking prevalence in high-income markets (≈ −2 % p.a.) and tightening regulation, which is accelerating the shift toward higher-margin NGPs and price-elastic premium pricing strategies.
For a deeper, data-rich assessment of BTI’s valuation dynamics, you may find ValueRay’s analytical dashboards worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (-10.75b TTM) > 0 and > 6% of Revenue (6% = 3.11b TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 6.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.10% (prev -4.31%; Δ 0.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 16.29b > Net Income -10.75b (YES >=105%, WARN >=100%) |
| Net Debt (-4.40b) to EBITDA (20.68b) ratio: -0.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.21b) change vs 12m ago -1.14% (target <= -2.0% for YES) |
| Gross Margin 82.49% (prev 73.90%; Δ 8.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 45.23% (prev 29.04%; Δ 16.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.79 (EBITDA TTM 20.68b / Interest Expense TTM 4.30b) >= 6 (WARN >= 3) |
Altman Z'' 2.29
| (A) -0.02 = (Total Current Assets 13.88b - Total Current Liabilities 16.00b) / Total Assets 110.23b |
| (B) 0.21 = Retained Earnings (Balance) 22.99b / Total Assets 110.23b |
| (C) 0.14 = EBIT TTM 16.31b / Avg Total Assets 114.47b |
| (D) 0.74 = Book Value of Equity 46.75b / Total Liabilities 63.05b |
| Total Rating: 2.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.54
| 1. Piotroski 5.50pt |
| 2. FCF Yield 15.02% |
| 3. FCF Margin 36.14% |
| 4. Debt/Equity 0.75 |
| 5. Debt/Ebitda -0.21 |
| 6. ROIC - WACC (= 21.55)% |
| 7. RoE -20.99% |
| 8. Rev. Trend 55.30% |
| 9. EPS Trend 13.29% |
What is the price of BTI shares?
As of December 11, 2025, the stock is trading at USD 58.76 with a total of 4,010,098 shares traded.
Over the past week, the price has changed by +2.17%, over one month by +6.03%, over three months by +5.96% and over the past year by +66.83%.
Over the past week, the price has changed by +2.17%, over one month by +6.03%, over three months by +5.96% and over the past year by +66.83%.
Is BTI a buy, sell or hold?
British American Tobacco has received a consensus analysts rating of 3.40.
Therefor, it is recommend to hold BTI.
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the BTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 56.1 | -4.5% |
| Analysts Target Price | 56.1 | -4.5% |
| ValueRay Target Price | 76.4 | 30% |
BTI Fundamental Data Overview December 11, 2025
Market Cap GBP = 93.63b (124.81b USD * 0.7502 USD.GBP)
P/E Trailing = 30.9676
P/E Forward = 12.0482
P/S = 4.8761
P/B = 1.9962
P/EG = 0.4041
Beta = 0.06
Revenue TTM = 51.78b GBP
EBIT TTM = 16.31b GBP
EBITDA TTM = 20.68b GBP
Long Term Debt = 31.90b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.30b GBP (from shortTermDebt, last quarter)
Debt = 35.33b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.40b GBP (from netDebt column, last quarter)
Enterprise Value = 124.55b GBP (93.63b + Debt 35.33b - CCE 4.40b)
Interest Coverage Ratio = 3.79 (Ebit TTM 16.31b / Interest Expense TTM 4.30b)
FCF Yield = 15.02% (FCF TTM 18.71b / Enterprise Value 124.55b)
FCF Margin = 36.14% (FCF TTM 18.71b / Revenue TTM 51.78b)
Net Margin = -20.75% (Net Income TTM -10.75b / Revenue TTM 51.78b)
Gross Margin = 82.49% ((Revenue TTM 51.78b - Cost of Revenue TTM 9.06b) / Revenue TTM)
Gross Margin QoQ = 83.59% (prev 83.20%)
Tobins Q-Ratio = 1.13 (Enterprise Value 124.55b / Total Assets 110.23b)
Interest Expense / Debt = 2.16% (Interest Expense 764.0m / Debt 35.33b)
Taxrate = 18.10% (1.01b / 5.57b)
NOPAT = 13.36b (EBIT 16.31b * (1 - 18.10%))
Current Ratio = 0.87 (Total Current Assets 13.88b / Total Current Liabilities 16.00b)
Debt / Equity = 0.75 (Debt 35.33b / totalStockholderEquity, last quarter 46.87b)
Debt / EBITDA = -0.21 (Net Debt -4.40b / EBITDA 20.68b)
Debt / FCF = -0.24 (Net Debt -4.40b / FCF TTM 18.71b)
Total Stockholder Equity = 51.18b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.75% (Net Income -10.75b / Total Assets 110.23b)
RoE = -20.99% (Net Income TTM -10.75b / Total Stockholder Equity 51.18b)
RoCE = 19.63% (EBIT 16.31b / Capital Employed (Equity 51.18b + L.T.Debt 31.90b))
RoIC = 26.60% (NOPAT 13.36b / Invested Capital 50.21b)
WACC = 5.05% (E(93.63b)/V(128.96b) * Re(6.29%) + D(35.33b)/V(128.96b) * Rd(2.16%) * (1-Tc(0.18)))
Discount Rate = 6.29% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.57%
[DCF Debug] Terminal Value 79.68% ; FCFE base≈16.22b ; Y1≈17.92b ; Y5≈23.23b
Fair Price DCF = 185.7 (DCF Value 403.71b / Shares Outstanding 2.17b; 5y FCF grow 12.09% → 3.0% )
EPS Correlation: 13.29 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 55.30 | Revenue CAGR: -2.95% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=4.81 | Chg30d=-0.054 | Revisions Net=-1 | Growth EPS=+5.7% | Growth Revenue=+2.9%
P/E Trailing = 30.9676
P/E Forward = 12.0482
P/S = 4.8761
P/B = 1.9962
P/EG = 0.4041
Beta = 0.06
Revenue TTM = 51.78b GBP
EBIT TTM = 16.31b GBP
EBITDA TTM = 20.68b GBP
Long Term Debt = 31.90b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.30b GBP (from shortTermDebt, last quarter)
Debt = 35.33b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -4.40b GBP (from netDebt column, last quarter)
Enterprise Value = 124.55b GBP (93.63b + Debt 35.33b - CCE 4.40b)
Interest Coverage Ratio = 3.79 (Ebit TTM 16.31b / Interest Expense TTM 4.30b)
FCF Yield = 15.02% (FCF TTM 18.71b / Enterprise Value 124.55b)
FCF Margin = 36.14% (FCF TTM 18.71b / Revenue TTM 51.78b)
Net Margin = -20.75% (Net Income TTM -10.75b / Revenue TTM 51.78b)
Gross Margin = 82.49% ((Revenue TTM 51.78b - Cost of Revenue TTM 9.06b) / Revenue TTM)
Gross Margin QoQ = 83.59% (prev 83.20%)
Tobins Q-Ratio = 1.13 (Enterprise Value 124.55b / Total Assets 110.23b)
Interest Expense / Debt = 2.16% (Interest Expense 764.0m / Debt 35.33b)
Taxrate = 18.10% (1.01b / 5.57b)
NOPAT = 13.36b (EBIT 16.31b * (1 - 18.10%))
Current Ratio = 0.87 (Total Current Assets 13.88b / Total Current Liabilities 16.00b)
Debt / Equity = 0.75 (Debt 35.33b / totalStockholderEquity, last quarter 46.87b)
Debt / EBITDA = -0.21 (Net Debt -4.40b / EBITDA 20.68b)
Debt / FCF = -0.24 (Net Debt -4.40b / FCF TTM 18.71b)
Total Stockholder Equity = 51.18b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.75% (Net Income -10.75b / Total Assets 110.23b)
RoE = -20.99% (Net Income TTM -10.75b / Total Stockholder Equity 51.18b)
RoCE = 19.63% (EBIT 16.31b / Capital Employed (Equity 51.18b + L.T.Debt 31.90b))
RoIC = 26.60% (NOPAT 13.36b / Invested Capital 50.21b)
WACC = 5.05% (E(93.63b)/V(128.96b) * Re(6.29%) + D(35.33b)/V(128.96b) * Rd(2.16%) * (1-Tc(0.18)))
Discount Rate = 6.29% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.57%
[DCF Debug] Terminal Value 79.68% ; FCFE base≈16.22b ; Y1≈17.92b ; Y5≈23.23b
Fair Price DCF = 185.7 (DCF Value 403.71b / Shares Outstanding 2.17b; 5y FCF grow 12.09% → 3.0% )
EPS Correlation: 13.29 | EPS CAGR: 0.0% | SUE: 0.0 | # QB: 0
Revenue Correlation: 55.30 | Revenue CAGR: -2.95% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=4.81 | Chg30d=-0.054 | Revisions Net=-1 | Growth EPS=+5.7% | Growth Revenue=+2.9%
Additional Sources for BTI Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle